Cuál es el precio por Humanwell Healthcare (Group) Co.,Ltd. (600079)

Precio por Humanwell Healthcare (Group) Co.,Ltd. (600079) es de$2.68

Cuál es la capitalización de mercado por Humanwell Healthcare (Group) Co.,Ltd. (600079)

Capitalización de mercado por Humanwell Healthcare (Group) Co.,Ltd. (600079) es $4.37B

Ingresos de Humanwell Healthcare (Group) Co.,Ltd. (600079)

Humanwell Healthcare (Group) Co.,Ltd. operates internationally, delivering a wide spectrum of healthcare solutions across regions including the Asia Pacific, North America, and Africa. The company's diverse product range features pharmaceuticals for pain management, such as anesthetics and analgesics, alongside a significant focus on women's health, providing items for reproductive planning, emergency contraception, and general wellness. They also produce central nervous system (CNS) medications addressing conditions like bronchitis, migraines, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, brain injuries, and peripheral vascular disorders. Furthermore, their offerings extend to traditional herbal remedies for common ailments such as colds and flu, rheumatoid arthritis, dermatological concerns, hepatitis, urinary tract infections, and memory impairment. Humanwell also supplies anti-infective agents, a variety of over-the-counter (OTC) drugs for digestive complaints, cold and flu relief, anti-inflammatory purposes, infections, and nutritional supplements. Complementing these, they offer specific treatments aimed at cardiovascular, gastrointestinal, and reproductive system diseases. Established in Wuhan, China, in 1993, the enterprise was initially known as Wuhan Humanwell Healthcare (Group) Co., Ltd. before adopting its current name, Humanwell Healthcare (Group) Co.,Ltd., in March 2013.

Año	Ingresos	Cambiar
Not enough data for the provided dates.

Año

Ingresos

Cambiar

Not enough data for the provided dates.

Empresa	Ingresos	Diferencia de ingresos	País
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Galderma Group AG GALD.SW	-	-	CH
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$6.61B	-	IN

Empresa

Ingresos

Diferencia de ingresos

País